{"id":"https://openalex.org/W3036409259","doi":"https://doi.org/10.1111/jdv.16598","title":"Efficacy and safety of oral tranexamic acid as an adjuvant in Indian patients with melasma: a prospective, interventional, single\u2010centre, triple\u2010blind, randomized, placebo\u2010control, parallel group study","display_name":"Efficacy and safety of oral tranexamic acid as an adjuvant in Indian patients with melasma: a prospective, interventional, single\u2010centre, triple\u2010blind, randomized, placebo\u2010control, parallel group study","publication_year":2020,"publication_date":"2020-06-22","ids":{"openalex":"https://openalex.org/W3036409259","doi":"https://doi.org/10.1111/jdv.16598","mag":"3036409259","pmid":"https://pubmed.ncbi.nlm.nih.gov/32567734"},"language":"en","primary_location":{"id":"doi:10.1111/jdv.16598","doi":"https://doi.org/10.1111/jdv.16598","is_oa":false,"landing_page_url":"https://doi.org/10.1111/jdv.16598","pdf_url":null,"source":{"id":"https://openalex.org/S137740113","display_name":"Journal of the European Academy of Dermatology and Venereology","issn_l":"0926-9959","issn":["0926-9959","1468-3083"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-a","doyens","jufo-2","ki-jl-2","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of the European Academy of Dermatology and Venereology","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5050846503","display_name":"Khushboo Minni","orcid":"https://orcid.org/0000-0002-6463-3953","observed_orcids":["https://orcid.org/0000-0002-6463-3953"]},"institutions":[{"id":"https://openalex.org/I4210154490","display_name":"K. J. Somaiya Hospital & Research Centre","ror":"https://ror.org/047zg7c19","country_code":"IN","type":"healthcare","lineage":["https://openalex.org/I4210154490"]},{"id":"https://openalex.org/I50783897","display_name":"K J Somaiya Medical College","ror":"https://ror.org/05f71q776","country_code":"IN","type":"education","lineage":["https://openalex.org/I4405262393","https://openalex.org/I50783897"]}],"countries":["IN"],"is_corresponding":false,"raw_author_name":"K. Minni","raw_affiliation_strings":["Department of Dermatology, Venereology and Leprosy, K.J. Somaiya Medical College and Research Centre, Mumbai, Maharashtra, India"],"raw_orcid":"https://orcid.org/0000-0002-6463-3953","affiliations":[{"raw_affiliation_string":"Department of Dermatology, Venereology and Leprosy, K.J. Somaiya Medical College and Research Centre, Mumbai, Maharashtra, India","institution_ids":["https://openalex.org/I4210154490","https://openalex.org/I50783897"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5089033888","display_name":"Shital Poojary","orcid":"https://orcid.org/0000-0001-7816-4230","observed_orcids":["https://orcid.org/0000-0001-7816-4230"]},"institutions":[{"id":"https://openalex.org/I4210154490","display_name":"K. J. Somaiya Hospital & Research Centre","ror":"https://ror.org/047zg7c19","country_code":"IN","type":"healthcare","lineage":["https://openalex.org/I4210154490"]},{"id":"https://openalex.org/I50783897","display_name":"K J Somaiya Medical College","ror":"https://ror.org/05f71q776","country_code":"IN","type":"education","lineage":["https://openalex.org/I4405262393","https://openalex.org/I50783897"]}],"countries":["IN"],"is_corresponding":true,"raw_author_name":"S. Poojary","raw_affiliation_strings":["Department of Dermatology, Venereology and Leprosy, K.J. Somaiya Medical College and Research Centre, Mumbai, Maharashtra, India"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Dermatology, Venereology and Leprosy, K.J. Somaiya Medical College and Research Centre, Mumbai, Maharashtra, India","institution_ids":["https://openalex.org/I4210154490","https://openalex.org/I50783897"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5089033888"],"corresponding_institution_ids":["https://openalex.org/I4210154490","https://openalex.org/I50783897"],"apc_list":{"value":3600,"currency":"USD","value_usd":3600},"apc_paid":null,"fwci":3.1481,"has_fulltext":false,"cited_by_count":29,"citation_normalized_percentile":{"value":0.9278799,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":93,"max":99},"biblio":{"volume":"34","issue":"11","first_page":"2636","last_page":"2644"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11172","display_name":"Dermatologic Treatments and Research","score":0.9883000254631042,"subfield":{"id":"https://openalex.org/subfields/2708","display_name":"Dermatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11172","display_name":"Dermatologic Treatments and Research","score":0.9883000254631042,"subfield":{"id":"https://openalex.org/subfields/2708","display_name":"Dermatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11144","display_name":"melanin and skin pigmentation","score":0.01080000028014183,"subfield":{"id":"https://openalex.org/subfields/1307","display_name":"Cell Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10392","display_name":"Cutaneous Melanoma Detection and Management","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/melasma","display_name":"melasma","score":0.9359999895095825},{"id":"https://openalex.org/keywords/oral-tranexamic-acid","display_name":"oral tranexamic acid","score":0.9279999732971191},{"id":"https://openalex.org/keywords/fluocinolone-acetonide","display_name":"fluocinolone acetonide","score":0.9020000100135803},{"id":"https://openalex.org/keywords/all-trans-retinoic-acid","display_name":"all-trans retinoic acid","score":0.7680000066757202},{"id":"https://openalex.org/keywords/hydroquinone","display_name":"hydroquinone","score":0.9919999837875366},{"id":"https://openalex.org/keywords/adjuvant-therapy","display_name":"adjuvant therapy","score":0.8339999914169312},{"id":"https://openalex.org/keywords/hypopigmentation","display_name":"hypopigmentation","score":0.7409999966621399},{"id":"https://openalex.org/keywords/recurrence","display_name":"recurrence","score":0.8059999942779541},{"id":"https://openalex.org/keywords/ranitidine","display_name":"ranitidine","score":0.8109999895095825},{"id":"https://openalex.org/keywords/indian-patients","display_name":"Indian patients","score":0.7860000133514404},{"id":"https://openalex.org/keywords/treatment-efficacy-and-safety","display_name":"treatment efficacy and safety","score":0.5699999928474426},{"id":"https://openalex.org/keywords/plasmin-inhibitor","display_name":"plasmin inhibitor","score":0.5429999828338623}],"concepts":[{"id":"https://openalex.org/C2776677263","wikidata":"https://www.wikidata.org/wiki/Q305190","display_name":"Melasma","level":2,"score":0.9413185119628906},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9349987506866455},{"id":"https://openalex.org/C2779637338","wikidata":"https://www.wikidata.org/wiki/Q418666","display_name":"Tranexamic acid","level":3,"score":0.9311919212341309},{"id":"https://openalex.org/C2777463590","wikidata":"https://www.wikidata.org/wiki/Q924467","display_name":"Fluocinolone acetonide","level":2,"score":0.6839115619659424},{"id":"https://openalex.org/C27081682","wikidata":"https://www.wikidata.org/wiki/Q269829","display_name":"Placebo","level":3,"score":0.5519480109214783},{"id":"https://openalex.org/C168563851","wikidata":"https://www.wikidata.org/wiki/Q1436668","display_name":"Randomized controlled trial","level":2,"score":0.49695613980293274},{"id":"https://openalex.org/C2777785397","wikidata":"https://www.wikidata.org/wiki/Q492194","display_name":"Group B","level":2,"score":0.4730597734451294},{"id":"https://openalex.org/C16005928","wikidata":"https://www.wikidata.org/wiki/Q171171","display_name":"Dermatology","level":1,"score":0.3959342837333679},{"id":"https://openalex.org/C42219234","wikidata":"https://www.wikidata.org/wiki/Q131130","display_name":"Anesthesia","level":1,"score":0.35913342237472534},{"id":"https://openalex.org/C141071460","wikidata":"https://www.wikidata.org/wiki/Q40821","display_name":"Surgery","level":1,"score":0.3326435685157776},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.0},{"id":"https://openalex.org/C204787440","wikidata":"https://www.wikidata.org/wiki/Q188504","display_name":"Alternative medicine","level":2,"score":0.0},{"id":"https://openalex.org/C2991743468","wikidata":"https://www.wikidata.org/wiki/Q166019","display_name":"Blood loss","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008548","descriptor_name":"Melanosis","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D011446","descriptor_name":"Prospective Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014148","descriptor_name":"Tranexamic Acid","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D014212","descriptor_name":"Tretinoin","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D044466","descriptor_name":"Asian People","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1111/jdv.16598","doi":"https://doi.org/10.1111/jdv.16598","is_oa":false,"landing_page_url":"https://doi.org/10.1111/jdv.16598","pdf_url":null,"source":{"id":"https://openalex.org/S137740113","display_name":"Journal of the European Academy of Dermatology and Venereology","issn_l":"0926-9959","issn":["0926-9959","1468-3083"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-a","doyens","jufo-2","ki-jl-2","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of the European Academy of Dermatology and Venereology","raw_type":"journal-article"},{"id":"pmid:32567734","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/32567734","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of the European Academy of Dermatology and Venereology : JEADV","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":1.0}],"study_designs":[{"id":"https://openalex.org/study-designs/randomized-controlled-trial","display_name":"Randomized Controlled Trial"},{"id":"https://openalex.org/study-designs/clinical-trial","display_name":"Clinical Trial"}],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":27,"referenced_works":["https://openalex.org/W1665593068","https://openalex.org/W1964340452","https://openalex.org/W1966326996","https://openalex.org/W1968055097","https://openalex.org/W1981757494","https://openalex.org/W1982011952","https://openalex.org/W1990368513","https://openalex.org/W2014761783","https://openalex.org/W2015726741","https://openalex.org/W2027233384","https://openalex.org/W2036468563","https://openalex.org/W2055984976","https://openalex.org/W2093769400","https://openalex.org/W2099207264","https://openalex.org/W2099602020","https://openalex.org/W2134643552","https://openalex.org/W2148657141","https://openalex.org/W2165127297","https://openalex.org/W2181711984","https://openalex.org/W2319415279","https://openalex.org/W2346719544","https://openalex.org/W2358194816","https://openalex.org/W2408311030","https://openalex.org/W2503691280","https://openalex.org/W2770310317","https://openalex.org/W2990719393","https://openalex.org/W3031215103"],"related_works":["https://openalex.org/W1665593068","https://openalex.org/W3004983131","https://openalex.org/W4320081715","https://openalex.org/W2903589812","https://openalex.org/W3046573300","https://openalex.org/W3197561205","https://openalex.org/W2014761783","https://openalex.org/W3169478296","https://openalex.org/W2896614951","https://openalex.org/W4401975788"],"abstract_inverted_index":{"BACKGROUND:":[0],"Melasma":[1],"is":[2,283],"a":[3,17,102,285,306],"chronic":[4],"recalcitrant":[5],"pigmentary":[6],"disorder":[7],"whose":[8],"treatment":[9],"frustrates":[10],"physician":[11],"and":[12,28,37,54,93,100,112,117,128,130,148,155,158,183,189,293,310],"patient":[13],"alike.":[14],"Tranexamic":[15],"acid,":[16],"plasmin":[18],"inhibitor,":[19],"has":[20],"demonstrated":[21],"hypopigmenting":[22],"properties.":[23],"AIM:":[24],"To":[25],"compare":[26],"safety":[27],"efficacy":[29],"of":[30,32,45,58,61,259,290],"combination":[31,40,104,303],"oral":[33,88,94],"tranexamic":[34,89,281],"acid":[35,90,282],"(TXA)":[36],"topical":[38,46],"fluocinolone-based":[39,301],"cream":[41,105,133,304],"(FbTC)":[42],"with":[43,78,181],"that":[44],"FbTC":[47],"alone":[48],"in":[49,81,174,186,197,210,229,232,237,268,273],"melasma.":[50],"METHOD:":[51],"One":[52],"hundred":[53],"eighty":[55],"patients":[56,57,80,86,176,185,205,225],"facial":[59],"melasma":[60,143,291],"either":[62],"sex":[63],"attending":[64],"dermatology":[65],"OPD":[66],"were":[67,72,165,172,261],"screened.":[68],"Consenting":[69],"130":[70],"participants":[71],"randomized":[73],"into":[74],"two":[75],"blinded":[76],"groups":[77],"65":[79],"each":[82],"group.":[83],"Group":[84,118],"A":[85,188,231,244,270],"received":[87],"250":[91],"mg":[92,97],"ranitidine":[95],"150":[96],"twice":[98],"daily":[99],"applied":[101],"triple":[103,302],"containing":[106],"fluocinolone":[107],"acetonide":[108],"0.01%,":[109],"tretinoin":[110],"0.05%":[111],"hydroquinone":[113],"2%":[114],"once":[115],"daily,":[116],"B":[119,216,253,275],"was":[120,139,194,266],"asked":[121],"to":[122,214,234,251,287,300,311],"take":[123],"placebo":[124],"tablets":[125],"(calcium":[126],"lactate":[127],"multivitamin)":[129],"apply":[131],"the":[132,179,199,288],"only":[134,235],"for":[135,162,305],"12":[136],"weeks.":[137],"Response":[138],"evaluated":[140],"using":[141,167],"modified":[142],"area":[144],"severity":[145],"index":[146],"(mMASI)":[147],"graded":[149],"mMASI":[150,211],"improvement":[151,208,228,248,309],"at":[152,159,218,276],"4th,":[153],"8th":[154],"12th":[156,222],"weeks,":[157],"24th":[160,241,277],"week":[161],"recurrence.":[163,313],"Data":[164],"analysed":[166,173],"SPSS":[168],"software.":[169],"RESULTS:":[170],"Results":[171],"120":[175],"who":[177],"completed":[178],"study":[180],"61":[182],"59":[184],"group":[187,202,215,230,238,243,252,269,274],"B,":[190],"respectively.":[191],"Demographic":[192],"profile":[193],"equally":[195],"distributed":[196],"both":[198],"groups.":[200],"In":[201],"A,":[203],"13.1%":[204],"showed":[206],"marked":[207,227],"(>75%)":[209],"as":[212,249,297],"compared":[213,250],"(1.7%)":[217],"4th":[219],"week.":[220,278],"By":[221],"week,":[223,242],"65.6%":[224],"had":[226,246],"contrast":[233],"27.1%":[236],"B.":[239],"At":[240],"(65.6%)":[245],"sustained":[247,308],"(11.9%)":[254],"despite":[255],"stopping":[256],"treatment;":[257],"all":[258],"which":[260],"statistically":[262],"significant.":[263],"Recurrence":[264],"observed":[265],"18.03%":[267],"vs.":[271],"64.4%":[272],"CONCLUSION:":[279],"Oral":[280],"definitely":[284],"boon":[286],"armamentarium":[289],"management":[292],"should":[294],"be":[295],"used":[296],"an":[298],"adjuvant":[299],"faster,":[307],"prevent":[312]},"counts_by_year":[{"year":2026,"cited_by_count":5},{"year":2025,"cited_by_count":2},{"year":2024,"cited_by_count":6},{"year":2023,"cited_by_count":8},{"year":2022,"cited_by_count":5},{"year":2021,"cited_by_count":3}],"updated_date":"2026-11-07T11:25:07.637180","created_date":"2020-06-25T00:00:00"}